Rhythm Pharmaceuticals Inc
RYTM108.750USD
+2.170+2.04%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
7.25BMarket Cap
LossP/E TTM
Rhythm Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
130.13M
68.06%
EPS(YoY)
-4.34
-35.46%
Analyst Rating
BUY
2025-11-25
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 130.13M, with a year-on-year change of 68.06%.
What is the Earnings Per Share (EPS) of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -4.338, with a year-on-year change of -35.46%.
What is the net income of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its net income was -264.57M, with a year-on-year change of -43.26%.
What is the net margin of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -200.27%, with a year-on-year change of 16.04%.
What is the gross margin of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 89.73%, with a year-on-year change of 1.98%.
What is the debt-to-asset ratio of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 27.99%, with a year-on-year change of -12.24%.
What is the Return on Equity (ROE) of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -276.33%, with a year-on-year change of -224.71%.
What is the Return on Assets (ROA) of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -71.89%, with a year-on-year change of -39.21%.
What is the operating profit of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -265.50M, with a year-on-year change of -44.02%.
What are the current assets of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its current assets were 374.20M, with a year-on-year change of 21.39%.
What are the total assets of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its total assets of Rhythm Pharmaceuticals Inc were 392.27M, with a year-on-year change of 17.89%.
What are the total liabilities of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Rhythm Pharmaceuticals Inc were 227.72M, with a year-on-year change of 39.72%.
What is the total equity of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its total equity of Rhythm Pharmaceuticals Inc was 164.55M, with a year-on-year change of -3.07%.
What is the net operating income of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Rhythm Pharmaceuticals Inc was -260.60M, with a year-on-year change of -41.11%.
What is the net investment of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its net investment of Rhythm Pharmaceuticals Inc was -48.17M, with a year-on-year change of -750.36%.
What is the net financing of Rhythm Pharmaceuticals Inc?
According to Rhythm Pharmaceuticals Inc's FY2024 earnings report, its net financing of Rhythm Pharmaceuticals Inc was 191.24M, with a year-on-year change of 157.16%.
